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Summary
Background: We investigated the predictors of the no-reﬂow phenomenon after per-
cutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) patients
with plaque rupture (PR).
Methods: The study group comprised 112 AMI patients who underwent pre- and post-
PCI intravascular ultrasound (IVUS) and stent implantation. Angiographic no-reﬂow
was deﬁned as TIMI ﬂow grade 0, 1, and 2 after PCI. IVUS ﬁndings included multiple
ruptured plaques (PRs separated by a >5-mm length of artery containing smooth
lumen contours), thrombus (had a layered lobulated appearance, evidence of blood
ﬂow within the mass, and speckling or scintillation), and plaque prolapse (tissue
extrusion through the stent struts).
Results: Of 112 patients, no-reﬂow was observed in 17 patients (15.2%). High-
sensitivity C-reactive protein (hs-CRP) was signiﬁcantly higher (6.2± 6.0mg/dl vs.
2.2± 2.9mg/dl, p = 0.002) and baseline TIMI ﬂow grade was signiﬁcantly lower in
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no-reﬂow group (TIMI ﬂow grade < 3: 59% vs. 18%, p < 0.001). Lesion site plaque plus
media area was signiﬁcantly greater (12.9± 2.6mm2 vs. 10.8± 4.2mm2, p = 0.009),
remodeling index was signiﬁcantly higher (1.14± 0.17 vs. 1.03± 0.20, p = 0.031),
and the presence of IVUS-detected thrombus (88% vs. 56%, p = 0.012), culprit lesion
multiple PRs (71% vs. 37%, p = 0.009), and plaque prolapse (65% vs. 34%, p = 0.015)
were signiﬁcantly more common in no-reﬂow group. In the multivariate analysis,
plaque prolapse (OR = 33.02; 95% CI 3.38—322.75, p = 0.003), hs-CRP (OR = 1.03; 95% CI
1.01—1.05, p = 0.013), and culprit lesion multiple PRs (OR = 15.73; 95% CI 1.61—153.46,
p = 0.018) were independent predictors of post-PCI no-reﬂow in AMI patients with PR.
Conclusions: Elevated hs-CRP and IVUS-detected multiple PRs and plaque prolapse are
associated with no-reﬂow after PCI for PR-containing culprit lesion in infarct-related
arteries in AMI patients.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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ticles and a chemiluminescent immunoenzymatic
assay (Beckman, Coulter Inc., Fullerton, CA, USA).
The serum levels of total cholesterol, triglyc-© 2008 Japanese Colleg
reserved.
ntroduction
he no-reﬂow phenomenon is observed frequently
fter thrombolysis or catheter-based percutaneous
oronary intervention (PCI) for acute myocardial
nfarction (AMI) [1—3]. Several recent studies have
uggested that pre-PCI intravascular ultrasound
IVUS) ﬁndings may be associated with the occur-
ence of the angiographic no-reﬂow phenomenon
uring PCI in patients with AMI [4—8]. Many vulner-
ble plaque characteristics are associated with the
evelopment of AMI, especially, rupture of a vulner-
ble plaque and subsequent thrombus formation is
he most important mechanism leading to an AMI
9,10].
It would be valuable to be able to predict which
actors are associated with distal embolization and
o-reﬂow in AMI patients with plaque rupture (PR).
herefore, the purpose of the present study was to
ttempt to identify pre- and post-PCI IVUS ﬁndings
hat are the predictors of no-reﬂow after PCI for PR-
ontaining culprit lesions in infarct-related arteries
n AMI patients.
ethods
atient population
rom August 2006 to July 2007, we identiﬁed a
otal of 112 patients with a ﬁrst AMI who under-
ent pre-PCI IVUS within 24 h from symptom onset,
ho had culprit lesion PR, were stented success-
ully, and had post-PCI IVUS imaging. We excluded
atients with prior MI, subacute or late stent throm-
osis, restenosis after stenting, coronary artery
ypass graft failure, patients studied with IVUS
ore than 24 h after symptom onset, and patients
n whom adequate IVUS images could not be
btained.
e
h
b
CThe presence of ST-segment elevation MI was
etermined by >30min of continuous chest pain,
new ST-segment elevation≥ 2mm on at least
wo contiguous electrocardiographic leads, and
reatine kinase-MB > 3 times normal. The pres-
nce of non-ST-segment elevation MI was diagnosed
y chest pain and a positive cardiac biochemical
arker without new ST-segment elevation. Infarct-
elated arteries were identiﬁed using a combination
f electrocardiographic ﬁndings, left ventricu-
ar wall motion abnormalities on left ventricular
ngiogram or echocardiogram, and coronary angio-
raphic ﬁndings.
All 112 infarct lesions were treated with
tent implantation: 47 with sirolimus-eluting stents
Cypher stent, Cordis, Johnson and Johnson, Miami
akes, FL, USA), 25 with paclitaxel-eluting stents
Taxus stent, Boston Scientiﬁc, Boston, MA, USA),
nd 40 with bare-metal stents. The protocol was
pproved by the institutional review board. Hospi-
al records of all patients were reviewed to obtain
linical demographics and medical history.
aboratory ﬁndings
eripheral blood samples were obtained before
VUS study using direct venipuncture. The blood
amples were centrifuged, and serum was removed
nd stored at −70 ◦C until the assay could be per-
ormed. Absolute creatine kinase-MB levels were
etermined by radioimmunoassay (Dade Behring
nc., Miami, FL, USA). Cardiac-speciﬁc troponin
levels were measured using paramagnetic par-ride, low-density lipoprotein cholesterol, and
igh-density lipoprotein cholesterol were measured
y standard enzymatic methods. High-sensitivity
-reactive protein (hs-CRP) was analyzed turbidi-
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by the average of the proximal and distal refer-
ence EEM CSA. Positive remodeling was deﬁned as
a remodeling index >1.05, intermediate remodeling
as a remodeling index between 0.95 and 1.05, and38
metrically with sheep antibodies against human
CRP; this has been validated against the Dade
Behring method [11].
No-reﬂow and quantitative coronary
angiography (QCA) analysis
No-reﬂow was deﬁned as post-PCI thrombolysis in
myocardial infarction (TIMI) grade 0, 1, or 2 ﬂow
in the absence of mechanical obstruction. Nor-
mal reﬂow was deﬁned as TIMI grade 3 ﬂow. On
this basis, patients were divided into two groups,
a no-reﬂow group (n = 17) and a normal reﬂow
group (n = 95). If TIMI ﬂow post-PCI was 0, 1, or 2
in the absence of angiographic stenosis, repeated
IVUS was performed to exclude the possibility of
mechanical vessel obstruction.
Coronary angiogram was analyzed with vali-
dated QCA system (Phillips H5000 or Allura DCI
program, Philips Medical Systems, Eindhoven, the
Netherlands). The angiograms were interpreted by
individuals blinded to the IVUS ﬁndings. With the
outer diameter of the contrast-ﬁlled catheter as
the calibration standard, the minimal lumen diam-
eter, reference diameter, and lesion length were
measured in diastolic frames from orthogonal pro-
jections. Perfusion was evaluated according to TIMI
criteria [12].
IVUS imaging and analysis
All IVUS examinations were performed before and
after stenting after intracoronary administration of
300g nitroglycerin using a commercially available
IVUS system (Boston Scientiﬁc Corporation/SCIMed,
Minneapolis, MN, USA). The IVUS catheter was
advanced distal to the target lesion, and imaging
was performed retrograde to the aorto-ostial junc-
tion at an automatic pullback speed of 0.5mm/s.
IVUS analysis was performed according to the
American College of Cardiology Clinical Expert Con-
sensus Document on Standards for Acquisition,
Measurement, and Reporting of Intravascular Ultra-
sound Studies [13]. A ruptured plaque contained
a cavity that communicated with the lumen with
an overlying residual ﬁbrous cap fragment (Fig. 1).
Rupture sites separated by a length of artery con-
taining smooth lumen contours without cavities
were considered to represent different PRs (mul-
tiple PRs, Fig. 2) [14,15].At pre-PCI, we measured external elastic mem-
brane (EEM) and lumen cross-sectional area (CSA).
Plaque plus media (P&M) CSA was calculated as
EEM CSA minus lumen CSA, and plaque burden was
calculated as P&M CSA divided by EEM CSA. The
F
pigure 1 An example of plaque rupture and surrounding
hrombus.
esion was the site with the smallest lumen CSA;
f there were multiple image slices with the same
inimum lumen CSA, then the image slice with
he largest EEM and P&M was measured. Coro-
ary artery remodeling was assessed by comparing
he lesion site to the reference EEM CSA. Remod-
ling index was the lesion site EEM CSA dividedigure 2 An example of longitudinal image of multiple
laque rupture.
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performed to identify independent predictors of
no-reﬂow phenomenon. Univariable analyses were
ﬁrst conducted to identify potential risk factors for
no-reﬂow. The likelihood ratio test was used, and
the variables with a p value of <0.2 were included in
the multivariable model. Finally, a stepdown logis-
tic regression was performed. The least signiﬁcant
variable was dropped at each step until only covari-
ates with a p value < 0.05 remained. A p value < 0.05
was considered statistically signiﬁcant.
Results
Patient characteristics
Of 112 patients studied pre-PCI IVUS, no-reﬂow
was observed in 17 patients (15.2%) after PCI. The
baseline characteristics are summarized in Table 1.
There was a trend that PCI for acute ST-segment
elevation MI were more frequently associated with
no-reﬂow. No-reﬂow group had more hypertension
and more family history of coronary artery disease
compared with normal reﬂow group. The left ven-
tricular ejection fraction was signiﬁcantly lower,
white blood cell count was signiﬁcantly higher, and
baseline creatine kinase-MB, and cardiac-speciﬁc
troponin I levels were signiﬁcantly higher in no-
reﬂow group compared with normal reﬂow group.
There were no signiﬁcant differences in the use of
glycoprotein IIb/IIIa inhibitors and pre-PCI clopi-
dogrel loading. hs-CRP levels were signiﬁcantly
higher in no-reﬂow group compared with normal
reﬂow group (Fig. 4). Maximum creatine kinase-
MB and cardiac troponin I levels were signiﬁcantly
elevated after PCI in no-reﬂow group compared
with normal reﬂow group [creatine kinase-MB:
+15.8± 38.2U/l vs. −6.8± 26.2U/l, p < 0.001, and
cardiac-speciﬁc troponin I: +19.8± 35.6 ng/ml vs.
−1.8± 19.8 ng/ml, p < 0.001].Figure 3 An example of plaque prolapse.
egative remodeling as a remodeling index < 0.95
16]. Hypoechoic plaque was less bright compared
ith the reference adventitia. Hyperechoic, non-
alciﬁc plaque was as bright as or brighter than the
eference adventitia without acoustic shadowing.
alciﬁc plaque was hyperechoic with shadowing. A
alciﬁed lesion contained >90◦ of circumferential
esion calcium. Thrombus was an intraluminal mass
aving a layered or lobulated appearance, evidence
f blood ﬂow (microchannels) within the mass, and
peckling or scintillation [15,17].
At post-PCI, we measured the minimum stent
SA. Percent stent expansion was calculated
s minimum stent CSA divided by mean refer-
nce lumen CSA. Plaque prolapse was deﬁned as
issue extrusion through the stent strut at post-
ntervention (Fig. 3), and the volume of plaque
rolapse was calculated by subtracting lumen vol-
me from stent volume.
tatistical analysis
he Statistical Package for Social Sciences (SPSS)
or Windows, Version 15.0 (Chicago, IL, USA) was
sed for all analyses. Continuous variables were
resented as the mean value± 1 SD; comparisons
ere conducted by Student’s t-test or the Wilcoxon
ank-sum test if normality assumption was violated.
iscrete variables were presented as percentages
nd relative frequencies; comparisons were con-
ucted by chi-square statistics or Fisher’s exact
est as appropriate. Multivariable analysis was
Figure 4 The high-sensitivity C-reactive protein levels
according to the presence of no-reﬂow or normal reﬂow.
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Table 1 Baseline characteristics.
No-reﬂow (n = 17) Normal reﬂow (n = 95) p-Value
Age (years) 63.1± 15.4 62.5± 13.4 0.7
Male gender 10 (59) 56 (59) 1.0
Clinical presentation 0.092
NSTEMI 5 (29) 49 (52)
STEMI 12 (71) 46 (48)
Diabetes mellitus 8 (47) 39 (41) 0.6
Hypertension 15 (88) 56 (59) 0.021
Smoking 5 (29) 33 (35) 0.7
Family history of coronary disease 9 (53) 18 (19) 0.003
Ejection fraction (%) 42± 10 46± 10 0.023
Glycoprotein IIb/IIIa inhibitor use 5 (29) 31 (33) 0.8
Pre-PCI clopidogrel loading 16 (94) 92 (97) 0.6
White blood cells (103 mm−3) 9.9± 3.4 7.9± 1.6 0.010
Hemoglobin (g/dl) 11.8± 2.0 12.2± 1.8 0.6
Platelet count (103 mm−3) 232± 75 226± 55 0.6
Creatine kinase-MB (U/l) 30.7± 58.7 14.7± 14.6 <0.001
Cardiac-speciﬁc troponin I (ng/ml) 23.5± 52.8 5.5± 8.1 0.002
Creatinine (mg/dl) 1.4± 1.1 1.1± 0.9 0.3
Total cholesterol (mg/dl) 191± 58 171± 45 0.17
Triglyceride (mg/dl) 128± 18 142± 74 0.18
LDL cholesterol (mg/dl) 119± 53 101± 39 0.18
HDL cholesterol (mg/dl) 48± 6 43± 14 0.099
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DData are n (%), or mean± S.D. NSTEMI: non-ST-segment elevat
infarction; PCI: percutaneous coronary intervention; LDL: low-
Angiographic and procedural results
Coronary angiographic ﬁndings are summarized in
Table 2. There were no signiﬁcant differences in
culprit lesions, lesion sites, diseased vessel number,
and stent type. However, pre-PCI TIMI ﬂow grade
was signiﬁcantly lower, more stents were deployed,
stent diameter tended to be larger, stent length
was signiﬁcantly longer, inﬂation pressure was sig-
niﬁcantly higher, and QCA minimal lumen diameter
tended to be smaller in no-reﬂow group compared
with normal reﬂow group.
IVUS results
IVUS results are summarized in Table 3. The lesion
site EEM and P&M CSAs were signiﬁcantly larger
in no-reﬂow group compared with normal reﬂow
group. IVUS lesion length was signiﬁcantly longer
and remodeling index was signiﬁcantly higher in no-
reﬂow group compared with normal reﬂow group.
The presence of IVUS-detected thrombus was signif-
icantly more common in no-reﬂow group compared
with normal reﬂow group. Culprit lesion multiple
PRs were observed more frequently in no-reﬂow
group compared with normal reﬂow group (Fig. 5).
T
h
m
ayocardial infarction; STEMI: ST-segment elevation myocardial
ity lipoprotein; HDL: high-density lipoprotein.
Minimum stent CSA and stent expansion were sig-
iﬁcantly greater in no-reﬂow group compared with
ormal reﬂow group. Post-PCI plaque prolapse was
bserved more frequently (Fig. 5), and maximum
laque prolapse area and plaque prolapse volume
ere signiﬁcantly greater in no-reﬂow group com-
ared with normal reﬂow group.
ndependent predictors of no-reﬂow
ultivariable analysis was performed to deter-
ine independent predictors of no-reﬂow. The
ariables with p < 0.2 in univariable analysis were
ested. Post-PCI plaque prolapse (OR = 33.02; 95%
I 3.38—322.75, p = 0.003), hs-CRP (OR = 1.03; 95%
I 1.01—1.05, p = 0.013), and culprit lesion multi-
le PRs (OR = 15.73; 95% CI 1.61—153.46, p = 0.018)
ere the independent predictors of post-PCI no-
eﬂow in AMI patients with PR.
iscussionhe present study demonstrated that elevated
s-CRP levels and IVUS-detected culprit lesion
ultiple PRs and post-PCI plaque prolapse were
ssociated with no-reﬂow phenomenon after PCI
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Table 2 Coronary angiographic ﬁndings and procedural results.
No-reﬂow (n = 17) Normal reﬂow (n = 95) p-Value
Diseased vessel 0.6
Left main 0 (0) 2 (2)
Left anterior descending 8 (47) 47 (50)
Left circumﬂex 1 (6) 13 (14)
Right 8 (47) 33 (35)
Lesion site 0.4
Ostium 2 (12) 5 (5)
Proximal 8 (47) 39 (41)
Middle 7 (41) 41 (43)
Distal 0 (0) 10 (11)
Pre-PCI TIMI ﬂow grade 0.001
0 0 (0) 0 (0)
1 4 (24) 6 (6)
2 6 (35) 11 (12)
3 7 (41) 78 (82)
Diseased vessel number 0.6
1 9 (53) 57 (60)
2 3 (18) 23 (24)
3 5 (29) 15 (16)
Stent type 0.5
Sirolimus-eluting stent 5 (29) 42 (44)
Paclitaxel-eluting stent 5 (29) 20 (21)
Bare-metal stents 7 (41) 33 (35)
Number of stents 1.71± 0.69 1.17± 0.40 0.006
Stent diameter (mm) 3.56± 0.63 3.27± 0.42 0.091
Stent length (mm) 35.1± 13.3 24.0± 11.1 <0.001
Predilation 16 (94) 89 (94) 0.9
Inﬂation pressure (atm) 15.7± 2.9 14.1± 2.5 0.019
Post-PCI TIMI ﬂow grade <0.001
0 2 (12) 0 (0)
1 3 (18) 0 (0)
2 12 (71) 0 (0)
3 0 (0) 95 (100)
Reference diameter (mm) 3.60± 0.69 3.34± 0.64 0.10
Pre-MLD (mm) 0.73± 0.43 0.84± 0.44 0.068
Post-MLD (mm) 3.44± 0.88 3.23± 0.74 0.060
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aData are n (%), or mean± S.D. PCI: percutaneous coronary inte
lumen diameter.
or PR-containing culprit lesion in infarct-related
rteries in AMI patients. Our results demonstrate
hat high inﬂammatory status as well as distal
mbolization with aggressive stenting procedure
or the vulnerable plaque-containing lesions plays
primary role in the development of micro- and
acro-vascular obstruction and antegrade ﬂow
mpairment.
No-reﬂow was attributable to the embolizationf thrombus and plaque debris that results from
echanical fragmentation of the vulnerable culprit
laque by PCI [4—6]. The degree of ﬂow impairment
nd myocardial hypoperfusion may be proportional
t
i
P
tion; TIMI: thrombolysis in myocardial infarction; MLD: minimal
o the material embolized distally and the qual-
ty of the distal runoff. Several IVUS studies have
emonstrated that thrombus formation [4,5], posi-
ive remodeling [6,7], greater plaque burden [4,5],
nd decreased post-PCI plaque volume [5,8] were
he independent predictors of no-reﬂow in acute
oronary syndrome patients.
In the present study, we evaluated which lesions
re associated with no-reﬂow after stent implan-
ation for the PR-containing culprit lesions in
nfarct-related arteries in AMI patients. Multiple
Rs were the important predictor of no-reﬂow in
he present study. Goldstein et al. [18] reported
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Table 3 Intravascular ultrasound ﬁndings.
No-reﬂow (n = 17) Normal reﬂow (n = 95) p-Value
Reference
EEM CSA (mm2) 14.3± 3.9 13.2± 4.6 0.4
Lumen CSA (mm2) 9.9± 3.5 9.5± 3.2 0.8
P&M CSA (mm2) 4.3± 1.6 3.7± 2.2 0.2
Plaque burden (%) 30.1± 10.4 28.0± 12.1 0.5
Lesion site
EEM CSA (mm2) 16.2± 4.7 13.4± 4.6 0.024
Lumen CSA (mm2) 2.7± 1.5 2.6± 1.2 0.9
P&M CSA (mm2) 12.9± 2.6 10.8± 4.2 0.009
Plaque burden (%) 82.0± 11.4 79.4± 9.0 0.3
Lesion length (mm) 30.5± 15.6 21.4± 10.7 0.002
Thrombus 15 (88) 53 (56) 0.012
Arc of calcium (◦) 97± 108 109± 108 0.7
Plaque morphology 0.2
Hypoechoic 14 (83) 67 (71)
Hyperechoic, noncalciﬁc 3 (18) 10 (11)
Hyperechoic, calciﬁc 0 (0) 13 (14)
Mixed 0 (0) 5 (5)
Remodeling index 1.14± 0.17 1.03± 0.20 0.031
Remodeling pattern 0.3
Positive 9 (53) 41 (43)
Intermediate 6 (35) 26 (27)
Negative 2 (12) 28 (30)
Minimum stent CSA (mm2) 9.76± 3.75 8.20± 3.54 0.027
Stent expansion (%) 98.6± 28.4 86.3± 19.6 0.038
Maximum plaque prolapse area (mm2) 0.70± 0.43 0.25± 0.30 0.010
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iPlaque prolapse volume (mm3) 1.48± 1
Data are n (%), or mean± S.D. EEM: external elastic membran
that the presence of multiple complex plaques was
associated with a poor prognosis compared with
single complex plaque in AMI patients. Tanaka et
al. [19] reported that the presence of multiple
PRs was associated with an increased incidence of
recurrent acute coronary syndrome and repeated
intervention compared with single PR or no PR in
AMI patients. In the present study, PCI for culprit
lesions with IVUS-detected multiple PRs which may
reﬂect a more generalized inﬂammatory response
throughout the coronary tree caused no-reﬂow phe-
nomenon.
PRs tend to occur at a point where the ﬁbrous
cap is thinnest and most heavily inﬁltrated by
macrophages, indicating ongoing inﬂammation at
the site of plaque disruption [20]. There is also a
strong inﬂammatory response to the tissue injury
that occurs during an AMI, and the degree of
the inﬂammatory response might be an important
determinant of the clinical outcome [21]. CRP has
emerged as a simple tool for detecting systemic
inﬂammation in patients with subsequent coronary
events [22,23]. Several IVUS studies have demon-
I
s
r
r0.64± 0.95 0.018
A: cross-sectional area; P&M: plaque plus media.
trated an association between elevated CRP levels
nd culprit lesion PRs in AMI patients [19,24,25].
n the present study, hs-CRP levels were signiﬁ-
antly higher in patients with no-reﬂow compared
ith patients with normal reﬂow and hs-CRP was an
ndependent predictor of no-reﬂow in AMI patients
ith PR. Our results suggest that no-reﬂow occurs
requently after PCI for more vulnerable plaque
multiple PR)-containing culprit lesion in infarct-
elated arteries which is associated with strong
nﬂammatory response.
In the present study, post-PCI plaque prolapse
as associated with no-reﬂow after PCI for cul-
rit lesion in infarct-related arteries with PR.
ecently, we reported longer stent length and pre-
CI IVUS-detected PRs and positive remodeling
ould predict plaque prolapse, and plaque prolapse
as associated with myonecrosis after stenting for
nfarct-related artery in patients with AMI [26].
akovou et al. [27] reported that more aggres-
ive stent expansion was associated with increased
ate of in-hospital non-Q-wave MI. Kim et al. [28]
eported that creatine kinase-MB elevation was
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Rigure 5 The incidences of multiple plaque rupture and
laque prolapse according to the presence of no-reﬂow
r normal reﬂow.
igher in patients with post-PCI intra-stent plaque
rolapse. In the present study, stent length was
igniﬁcantly longer, stent expansion was signiﬁ-
antly greater, plaque prolapse developed more
requently, and post-PCI cardiac enzymes were
levated more signiﬁcantly in no-reﬂow group com-
ared with normal reﬂow group. Our results suggest
hat less aggressive PCI technique when treating
R-containing culprit lesions in AMI patients may
elp to avoid distal embolization and no-reﬂow.
tudy limitations
irst, this was a retrospective, single center study
f patients getting pre- and post-PCI IVUS, so is
ubject to limitations inherent in this type of clini-
al investigation. Second, the number of patients
as small. Thus, some selection bias cannot be
xcluded entirely. Third, IVUS imaging was per-
ormed at the discretion of the individual operators
eading to potential selection bias. Fourth, because
he CRP level was not measured serially after AMI, it
annot be ascertained whether the CRP elevations
re the result or the cause of the PR. Fifth, it is well
nown that myocardial necrosis promotes the syn-
hesis of CRP, and AMI patients show elevated serum
RP levels. In the present study, elevated serum hs-43
RP levels were not always associated with plaque
nstability in AMI patients. Sixth, long-term clinical
ollow-up was not available.
onclusions
levated hs-CRP levels and IVUS-detected culprit
esion multiple PRs and post-PCI plaque prolapse
ere associated with no-reﬂow phenomenon after
CI for infarct-related arteries in AMI patients with
R.
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